Ledger.Open graph →

SEC Form D · Amendment · filed October 17, 2016

Castle Creek Pharmaceuticals, LLC

Offering

$48.0M

Sold

$48.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

BEDMINSTER, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Patrick Morris · BEDMINSTER, NJDirector Timothy Cunniff · BEDMINSTER, NJDirector Greg Licholai · BEDMINSTER, NJExec Antonio Gracias · BEDMINSTER, NJDirector Jeffrey Aronin · BEDMINSTER, NJDirector Michael Derby · BEDMINSTER, NJExec · Director Kent Roers · Long Lake, MNDirector Vincent Campagna · NEW YORK, NYDirector Fawaz Al-Mubaraki · NEW YORK, NYExec · Director Fergus Healy · NEW YORK, NYExec Russell Valdez · NEW YORK, NYDirector Michael Shedosky · NEW YORK, NYDirector Susan G. O'Connell · Boston, MADirector Matthew N. Shea · Boston, MADirector Joshua Katz · New York, NYDirector Brett Anderson · Broomfield, COExec Jerry Dinges · Broomfield, COExec · Director Michael Sarkesian · Broomfield, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗